Beyond genome sequencing: Lineage tracking with barcodes to study the dynamics of evolution, infection, and cancer

Genomics

Volumn 104, Issue , 2014, Pages 417-430

  Blundell, Jamie R ^a   Levy, Sasha F ^b  

^a STANFORD UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Barcode; Evolution; Evolutionary dynamics; Lineage; Sequencing; Tracing; Tracking

Indexed keywords

ARTICLE; CLONAL VARIATION; DNA BARCODING; FITNESS; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC PROCEDURES; GENOME ANALYSIS; HOMOLOGOUS RECOMBINATION; HUMAN; INFECTION; LINEAGE TRACKING; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR EVOLUTION; MUTATION RATE; NONHUMAN; POLYMERASE CHAIN REACTION; POPULATION DYNAMICS; POPULATION SIZE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; CELL LINEAGE; DRUG RESISTANCE; GENETICS; GENOME; HIGH THROUGHPUT SEQUENCING; MUTATION; NEOPLASM; PROCEDURES;

CELL LINEAGE; DNA BARCODING, TAXONOMIC; DRUG RESISTANCE; EVOLUTION, MOLECULAR; GENOME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFECTION; MUTATION; NEOPLASMS;

EID: 84937512023     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2014.09.005     Document Type: Article

References (165)

1. Kvitek D.J., Sherlock G. Whole genome, whole population sequencing reveals that loss of signaling networks is the major adaptive strategy in a constant environment. PLoS Genet. 2013, 9:e1003972. 10.1371/journal.pgen.1003972.
2. Herron M.D., Doebeli M. Parallel evolutionary dynamics of adaptive diversification in Escherichia coli. PLoS Biol. 2013, 11:e1001490. 10.1371/journal.pbio.1001490.
3. Lang G.I., Rice D.P., Hickman M.J., Sodergren E., Weinstock G.M., Botstein D., et al. Pervasive genetic hitchhiking and clonal interference in forty evolving yeast populations. Nature 2013, 500:571-574. 10.1038/nature12344.
4. Lang G.I., Botstein D., Desai M.M. Genetic variation and the fate of beneficial mutations in asexual populations. Genetics 2011, 188:647-661. 10.1534/genetics.111.128942.
5. Barrick J.E., Yu D.S., Yoon S.H., Jeong H., Oh T.K., Schneider D., et al. Genome evolution and adaptation in a long-term experiment with Escherichia coli. Nature 2009, 461:1243-1247. 10.1038/nature08480.
6. Weinreich D.M., Delaney N.F., DePristo M.A., Hartl D.L. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 2006, 312:111-114. 10.1126/science.1123539.
7. Khan A.I., Dinh D.M., Schneider D., Lenski R.E., Cooper T.F. Negative epistasis between beneficial mutations in an evolving bacterial population. Science 2011, 332:1193-1196. 10.1126/science.1203801.
8. Ding L., Ellis M.J., Li S., Larson D.E., Chen K., Wallis J.W., et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010, 464:999-1005. 10.1038/nature08989.
9. Shah S.P., Morin R.D., Khattra J., Prentice L., Pugh T., Burleigh A., et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 2009, 461:809-813. 10.1038/nature08489.
10. Lee W., Jiang Z., Liu J., Haverty P.M., Guan Y., Stinson J. The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 2010, 465:473-477.
11. Mardis E., Ding L., Dooling D., Larson D., McLellan M. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 2009, 361(11):1058-1066. 10.1056/NEJMoa0903840.
12. International Cancer Genome Consortium, Hudson T.J., Anderson W., Artez A., Barker A.D., Bell C., et al. International network of cancer genome projects. Nature 2010, 464:993-998. 10.1038/nature08987.
13. Pleasance E.D., Cheetham R.K., Stephens P.J., McBride D.J., Humphray S.J., Greenman C.D., et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010, 463:191-196. 10.1038/nature08658.
14. Mwangi M.M., Wu S.W., Zhou Y., Sieradzki K., de Lencastre H., Richardson P., et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:9451-9456. 10.1073/pnas.0609839104.
15. Young B.C., Golubchik T., Batty E.M., Fung R., Larner-Svensson H., Votintseva A.A., et al. Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease. PNAS 2012, 109:4550-4555. 10.1073/pnas.1113219109.
16. Holden M.T.G., Hsu L.-Y., Kurt K., Weinert L.A., Mather A.E., Harris S.R., et al. A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res. 2013, 23:653-664. 10.1101/gr.147710.112.
17. Lynch M., Sung W., Morris K., Coffey N., Landry C.R., Dopman E.B., et al. A genome-wide view of the spectrum of spontaneous mutations in yeast. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9272-9277. 10.2307/25462959?ref=search-gateway:2beab32b742d6a9bf3c7395f0a042d35.
18. Lang G.I., Murray A.W. Estimating the per-base-pair mutation rate in the yeast Saccharomyces cerevisiae. Genetics 2008, 178:67-82. 10.1534/genetics.107.071506.
19. Lynch M. Rate, molecular spectrum, and consequences of human mutation. PNAS 2010, 107:961-968. 10.1073/pnas.0912629107.
20. Zhu Y.O., Siegal M.L., Hall D.W. Precise Estimates of Mutation Rate and Spectrum in Yeast 2014, 10.1073/pnas.1323011111.
21. Joseph S.B., Hall D.W. Spontaneous mutations in diploid Saccharomyces cerevisiae: more beneficial than expected. Genetics 2004, 168:1817-1825. 10.1534/genetics.104.033761.
22. Desai M.M., Fisher D.S., Murray A.W. The speed of evolution and maintenance of variation in asexual populations. Curr. Biol. 2007, 17:385-394. 10.1016/j.cub.2007.01.072.
23. Hegreness M., Shoresh N., Hartl D., Kishony R. An equivalence principle for the incorporation of favorable mutations in asexual populations. Science 2006, 311:1615-1617. 10.1126/science.1122469.
24. Perfeito L., Fernandes L., Mota C., Gordo I. Adaptive mutations in bacteria: high rate and small effects. Science 2007, 317:813-815. 10.1126/science.1142284.
25. Imhof M., Schlötterer C. Fitness effects of advantageous mutations in evolving Escherichia coli populations. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:1113-1117. 10.1073/pnas.98.3.1113.
26. Rozen D.E., de Visser J.A., Gerrish P.J. Fitness effects of fixed beneficial mutations in microbial populations. Curr. Biol. 2002, 12:1040-1045.
27. Stevens K.E., Sebert M.E. Frequent beneficial mutations during single-colony serial transfer of Streptococcus pneumoniae. PLoS Genet. 2011, 7:e1002232. 10.1371/journal.pgen.1002232.
28. Zeyl C., DeVisser J.A.G.M. Estimates of the Rate and Distribution of Fitness Effects of Spontaneous Mutation in Saccharomyces cerevisiae. Genetics 2001, 157:53-61.
29. Wloch D.M., Szafraniec K., Borts R.H., Korona R. Direct estimate of the mutation rate and the distribution of fitness effects in the yeast Saccharomyces cerevisiae. Genetics 2001, 159:441-452.
30. Hall D.W., Joseph S.B. A high frequency of beneficial mutations across multiple fitness components in Saccharomyces cerevisiae. Genetics 2010, 185:1397-1409. 10.1534/genetics.110.118307.
31. Desai M.M., Fisher D.S. Beneficial mutation selection balance and the effect of linkage on positive selection. Genetics 2007, 176:1759-1798. 10.1534/genetics.106.067678.
32. Fogle C.A., Nagle J.L., Desai M.M. Clonal interference, multiple mutations and adaptation in large asexual populations. Genetics 2008, 180:2163-2173. 10.1534/genetics.108.090019.
33. Gerrish P.J., Lenski R.E. The fate of competing beneficial mutations in an asexual population. Genetica 1998, 102-103:127-144. 10.1023/A:1017067816551.
34. Wilke C.O. The speed of adaptation in large asexual populations. Genetics 2004, 167:2045-2053. 10.1534/genetics.104.027136.
35. Bollback J.P., Huelsenbeck J.P. Clonal interference is alleviated by high mutation rates in large populations. Mol. Biol. Evol. 2007, 24:1397-1406. 10.1093/molbev/msm056.
36. Fisher D.S. Asexual evolution waves: fluctuations and universality. J. Stat. Mech. 2013, 2013:P01011. 10.1088/1742-5468/2013/01/P01011.
37. Desai M.M., Walczak A.M., Fisher D.S. Genetic diversity and the structure of genealogies in rapidly adapting populations. Genetics 2013, 193:565-585. 10.1534/genetics.112.147157.
38. Neher R.A., Hallatschek O. Genealogies of Rapidly Adapting Populations 2013, 10.1073/pnas.1213113110/-/DCSupplemental.
39. Salmon S.E., Smith B.A. Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. J. Clin. Invest. 1970, 49:1114-1121. 10.1172/JCI106327.
40. Michaelson J.S., Silverstein M., Wyatt J., Weber G., Moore R., Halpern E., et al. Predicting the survival of patients with breast carcinoma using tumor size. Cancer 2002, 95:713-723. 10.1002/cncr.10742.
41. König C., Simmen H.P., Blaser J. Bacterial concentrations in pus and infected peritoneal fluid-implications for bactericidal activity of antibiotics. J. Antimicrob. Chemother. 1998, 42:227-232. 10.1093/jac/42.2.227.
42. Wilson M.L., Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin. Infect. Dis. 2004, 38:1150-1158. 10.1086/383029.
43. Gullberg E., Cao S., Berg O.G., Ilbäck C., Sandegren L., Hughes D., et al. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathog. 2011, 7:e1002158. 10.1371/journal.ppat.1002158.
44. Hughes D., Andersson D.I. Selection of resistance at lethal and non-lethal antibiotic concentrations. Curr. Opin. Microbiol. 2012, 15:555-560. 10.1016/j.mib.2012.07.005.
45. Elena S.F., Lenski R.E. Evolution experiments with microorganisms: the dynamics and genetic bases of adaptation. Nat. Rev. Genet. 2003, 4:457-469. 10.1038/nrg1088.
46. BROCKHURST M.A., COLEGRAVE N., ROZEN D.E. Next-generation sequencing as a tool to study microbial evolution. Mol. Ecol. 2011, 20:972-980. 10.1111/j.1365-294X.2010.04835.x.
47. Behe M.J. Experimental evolution, loss-of-function mutations, and "the first rule of adaptive evolution,". Q. Rev. Biol. 2010, 85:419-445. 10.1086/656902.
48. Beaumont H.J.E., Gallie J., Kost C., Ferguson G.C., Rainey P.B. Experimental evolution of bet hedging. Nature 2009, 462:90-93. 10.1038/nature08504.
49. Kryazhimskiy S., Rice D.P., Jerison E.R., Desai M.M. Microbial evolution. Global epistasis makes adaptation predictable despite sequence-level stochasticity. Science 2014, 344:1519-1522.
50. Barrick J.E., Lenski R.E. Genome-wide mutational diversity in an evolving population of Escherichia coli. Cold Spring Harb. Symp. Quant. Biol. 2009, 74:119-129. 10.1101/sqb.2009.74.018.
51. Schmitt M.W., Kennedy S.R., Salk J.J. Detection of Ultra-Rare Mutations by Next-Generation Sequencing 2012, 10.1073/pnas.1208715109/-/DCSupplemental.
52. Watson H.W., Galton F. On the probability of the extinction of families. J. Anthropol. Inst. G. B. Irel. 1875, 4:138. 10.2307/2841222.
53. Conklin E.G. The Organization and Cell-lineage of the Ascidian Egg 1905.
54. Kretzschmar K., Watt F.M. Lineage tracing. Cell 2012, 148:33-45. 10.1016/j.cell.2012.01.002.
55. Sulston J.E., Schierenberg E., White J.G., Thomson J.N. The embryonic cell lineage of the nematode Caenorhabditis elegans. Dev. Biol. 1983, 100:64-119.
56. Kimmel C.B., Warga R.M., Schilling T.F. Origin and organization of the zebrafish fate map. Development 1990, 108:581-594.
57. Temple S. Division and differentiation of isolated CNS blast cells in microculture. Nature 1989, 340:471-473. 10.1038/340471a0.
58. Hallatschek O., Hersen P., Ramanathan S., Nelson D.R. Genetic drift at expanding frontiers promotes gene segregation. PNAS 2007, 104:19926-19930. 10.1073/pnas.0710150104.
59. Kao K.C., Sherlock G. Molecular characterization of clonal interference during adaptive evolution in asexual populations of Saccharomyces cerevisiae. Nat. Genet. 2008, 40:1499-1504. 10.1038/ng.280.
60. Barroso-Batista J., Sousa A., Lourenço M., Bergman M.-L., Sobral D., Demengeot J., et al. The first steps of adaptation of Escherichia coli to the gut are dominated by soft sweeps. PLoS Genet. 2014, 10:e1004182. 10.1371/journal.pgen.1004182.
61. Livet J., Weissman T.A., Kang H., Draft R.W., Lu J., Bennis R.A., et al. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 2007, 450:56-62. 10.1038/nature06293.
62. Salipante S.J., Horwitz M.S. Phylogenetic fate mapping. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:5448-5453. 10.1073/pnas.0601265103.
63. Winzeler E.A., Shoemaker D.D., AstromoffA., Liang H., Anderson K., Andre B., et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999, 285:901-906. 10.1126/science.285.5429.901.
64. Giaever G., Chu A.M., Ni L., Connelly C., Riles L., Véronneau S., et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 2002, 418:387-391. 10.1038/nature00935.
65. Hillenmeyer M.E., Fung E., Wildenhain J., Pierce S.E., Hoon S., Lee W., et al. The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 2008, 320:362-365. 10.1126/science.1150021.
66. Smith A.M., Heisler L.E., Mellor J., Kaper F., Thompson M.J., Chee M., et al. Quantitative phenotyping via deep barcode sequencing. Genome Res. 2009, 19:1836-1842. 10.1101/gr.093955.109.
67. Gresham D., Boer V.M., Caudy A., Ziv N., Brandt N.J., Storey J.D., et al. System-level analysis of genes and functions affecting survival during nutrient starvation in Saccharomyces cerevisiae. Genetics 2011, 187:299-317. 10.1534/genetics.110.120766.
68. Robinson D.G., Chen W., Storey J.D., Gresham D. Design and analysis of Bar-seq experiments. G3 2014, 4:11-18. 10.1534/g3.113.008565.
69. Mazurier F., Gan O.I., McKenzie J.L., Doedens M., Dick J.E. Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 2004, 103:545-552. 10.1182/blood-2003-05-1558.
70. Gerrits A., Dykstra B., Kalmykowa O.J., Klauke K., Verovskaya E., Broekhuis M.J.C., et al. Cellular barcoding tool for clonal analysis in the hematopoietic system. Blood 2010, 115:2610-2618. 10.1182/blood-2009-06-229757.
71. Lu R., NeffN.F., Quake S.R., Weissman I.L. Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding. Nat. Biotechnol. 2011, 29:928-933. 10.1038/nbt.1977.
72. Verovskaya E., Broekhuis M.J.C., Zwart E., Ritsema M., van Os R., de Haan G., et al. Heterogeneity of young and aged murine hematopoietic stem cells revealed by quantitative clonal analysis using cellular barcoding. Blood 2013, 122:523-532. 10.1182/blood-2013-01-481135.
73. Lenski R.E., Simpson S.C., Nguyen T.T. Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness. J. Bacteriol. 1994, 176:3140-3147.
74. Summers D. The kinetics of plasmid loss. Trends Biotechnol. 1991, 9:273-278. 10.1016/0167-7799(91)90089-Z.
75. Kawahata M., Amari S., Nishizawa Y., Akada R. A positive selection for plasmid loss in Saccharomyces cerevisiae using galactose-inducible growth inhibitory sequences. Yeast 1999, 15:1-10. 10.1002/(SICI)1097-0061(19990115)15:1<1::AID-YEA335>3.0.CO;2-9.
76. Paulsson J., Ehrenberg M. Noise in a minimal regulatory network: plasmid copy number control. Q. Rev. Biophys. 2001, 34:1-59.
77. Gietz R.D., Schiestl R.H. High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. Nat. Protoc. 2007, 2:31-34. 10.1038/nprot.2007.13.
78. Austin S., Ziese M., Sternberg N. A novel role for site-specific recombination in maintenance of bacterial replicons. Cell 1981, 25:729-736. 10.1016/0092-8674(81)90180-X.
79. Gilbertson L. Cre-lox recombination: cre-ative tools for plant biotechnology. Trends Biotechnol. 2003, 21:550-555. 10.1016/j.tibtech.2003.09.011.
80. Nagy A. Cre recombinase: the universal reagent for genome tailoring. Genesis 2000, 26:99-109. 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B.
81. Craig N.L., Nash H.A. E. coli integration host factor binds to specific sites in DNA. Cell 1984, 39:707-716. 10.1016/0092-8674(84)90478-1.
82. Landy A. Dynamic, structural, and regulatory aspects of lambda site-specific recombination. Annu. Rev. Biochem. 1989, 58:913-949. 10.1146/annurev.bi.58.070189.004405.
83. Lei M.G., Cue D., Alba J., Junecko J., Graham J.W., Lee C.Y. A single copy integration vector that integrates at an engineered site on the Staphylococcus aureus chromosome. BMC Res. Notes 2012, 5:5. 10.1186/1756-0500-5-5.
84. Luong T.T., Lee C.Y. Improved single-copy integration vectors for Staphylococcus aureus. J. Microbiol. Methods 2007, 70:186-190. 10.1016/j.mimet.2007.04.007.
85. Albert H., Dale E.C., Lee E., Ow D.W. Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. Plant J. 1995, 7:649-659. 10.1046/j.1365-313X.1995.7040649.x.
86. Siegel R.W., Jain R., Bradbury A. Using an in vivo phagemid system to identify non-compatible loxP sequences. FEBS Lett. 2001, 499:147-153. 10.1016/S0014-5793(01)02541-8.
87. Lee K., Zhang Y., Lee S.E. Saccharomyces cerevisiae ATM orthologue suppresses break-induced chromosome translocations. Nature 2008, 454:543-546. 10.1038/nature07054.
88. Kivioja T., Vähärautio A., Karlsson K., Bonke M., Enge M., Linnarsson S., et al. Counting absolute numbers of molecules using unique molecular identifiers. Nat. Methods 2012, 9:72-74. 10.1038/nmeth.1778.
89. Good B.H., Rouzine I.M., Balick D.J., Hallatschek O., Desai M.M. Distribution of fixed beneficial mutations and the rate of adaptation in asexual populations. PNAS 2012, 109:4950-4955. 10.1073/pnas.1119910109.
90. Lenski R.E., Travisano M. Dynamics of adaptation and diversification: a 10,000-generation experiment with bacterial populations. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:6808-6814. 10.2307/2365168?ref=no-x-route:15c57794559e34407e79924e062d5e58.
91. Ferguson G.C., Bertels F., Rainey P.B. Adaptive divergence in experimental populations of Pseudomonas fluorescens. V. Insight into the niche specialist fuzzy spreader compels revision of the model Pseudomonas radiation. Genetics 2013, 195:1319-1335.
92. Flohr R.C.E., Blom C.J., Rainey P.B., Beaumont H.J.E. Founder niche constrains evolutionary adaptive radiation. PNAS 2013, 110:20663-20668. 10.1073/pnas.1310310110.
93. Perron G.G., Lee A.E.G., Wang Y., Huang W.E., Barraclough T.G. Bacterial recombination promotes the evolution of multi-drug-resistance in functionally diverse populations. Proc. Biol. Sci. 2012, 279:1477-1484. 10.1098/rspb.2011.1933.
94. Hallatschek O., Hallatschek O., Nelson D.R., Nelson D.R. Gene surfing in expanding populations. Theor. Popul. Biol. 2008, 73:158-170. 10.1016/j.tpb.2007.08.008.
95. Arjan J.A., Visser M., Zeyl C.W., Gerrish P.J., Blanchard J.L., Lenski R.E. Diminishing returns from mutation supply rate in asexual populations. Science (New York, N.Y.) 1999, 283:404-406.
96. Tokuriki N., Jackson C.J., Afriat-Jurnou L., Wyganowski K.T., Tang R., Tawfik D.S. Diminishing returns and tradeoffs constrain the laboratory optimization of an enzyme. Nat. Commun. 2012, 3:1257. 10.1038/ncomms2246.
97. Chou H.H., Chiu H.C., Delaney N.F., Segre D., Marx C.J. Diminishing returns epistasis among beneficial mutations decelerates adaptation. Science 2011, 332:1190-1192. 10.1126/science.1203799.
98. Turnbaugh P.J., Bäckhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3:213-223. 10.1016/j.chom.2008.02.015.
99. Greenblum S., Turnbaugh P.J., Borenstein E. Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. PNAS 2012, 109:594-599. 10.1073/pnas.1116053109.
100. Cho I., Blaser M.J. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 2012, 13:260-270. 10.1038/nrg3182.
101. Lozupone C.A., Stombaugh J.I., Gordon J.I., Jansson J.K., Knight R. Diversity, stability and resilience of the human gut microbiota. Nature 2012, 489:220-230. 10.1038/nature11550.
102. Ding T., Schloss P.D. Dynamics and associations of microbial community types across the human body. Nature 2014, 509:357-360. 10.1038/nature13178.
103. Clemente J.C., Ursell L.K., Parfrey L.W., Knight R. The impact of the gut microbiota on human health: an integrative view. Cell 2012, 148:1258-1270. 10.1016/j.cell.2012.01.035.
104. Tikhonov M., Leach R.W., Wingreen N.S. Interpreting 16S metagenomic data without clustering to achieve sub-OTU resolution. ISME J. 2014, 10.1038/ismej.2014.117.
105. Caporaso J.G., Kuczynski J., Stombaugh J., Bittinger K., Bushman F.D., Costello E.K., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7:335-336. 10.1038/nmeth.f.303.
106. Bokulich N.A., Subramanian S., Faith J.J., Gevers D., Gordon J.I., Knight R., et al. Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing. Nat. Methods 2013, 10:57-59. 10.1038/nmeth.2276.
107. Navas-Molina J.A., Peralta-Sánchez J.M., González A., McMurdie P.J., Vázquez-Baeza Y., Xu Z., et al. Advancing our understanding of the human microbiome using QIIME. Methods Enzymol. 2013, 531:371-444. 10.1016/B978-0-12-407863-5.00019-8.
108. Rosen M.J., Callahan B.J., Fisher D.S., Holmes S.P. Denoising PCR-amplified metagenome data. BMC Bioinformatics 2012, 13:283. 10.1186/1471-2105-13-283.
109. Grenfell B.T., Pybus O.G., Gog J.R., Wood J.L.N., Daly J.M., Mumford J.A., et al. Unifying the epidemiological and evolutionary dynamics of pathogens. Science 2004, 303:327-332. 10.1126/science.1090727.
110. Holden M.T.G., Feil E.J., Lindsay J.A., Peacock S.J., Day N.P.J., Enright M.C., et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:9786-9791. 10.1073/pnas.0402521101.
111. Berngruber T.W., Froissart R., Choisy M., Gandon S. Evolution of virulence in emerging epidemics. PLoS Pathog. 2013, 9:e1003209. 10.1371/journal.ppat.1003209.
112. Galagan J.E. Genomic insights into tuberculosis. Nat. Rev. Genet. 2014, 15:307-320. 10.1038/nrg3664.
113. Nübel U., Dordel J., Kurt K., Strommenger B., Westh H., Shukla S.K., et al. A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathog. 2010, 6:e1000855. 10.1371/journal.ppat.1000855.
114. Luksza M., Lässig M. A predictive fitness model for influenza. Nature 2014, 507:57-61. 10.1038/nature13087.
115. Zanini F., Neher R.A. Quantifying selection against synonymous mutations in HIV-1 env evolution. J. Virol. 2013, 87:11843-11850. 10.1128/JVI.01529-13.
116. Russell C.A., Jones T.C., Barr I.G., Cox N.J., Garten R.J., Gregory V., et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 2008, 320:340-346. 10.1126/science.1154137.
117. Harris S.R., Feil E.J., Holden M.T.G., Quail M.A., Nickerson E.K., Chantratita N., et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science 2010, 327:469-474. 10.1126/science.1182395.
118. Smyth D.S., McDougal L.K., Gran F.W., Manoharan A., Enright M.C., Song J.-H., et al. Population structure of a hybrid clonal group of methicillin-resistant Staphylococcus aureus, ST239-MRSA-III. PLoS One 2010, 5:e8582. 10.1371/journal.pone.0008582.
119. Kurt K., Rasigade J.-P., Laurent F., Goering R.V., Zemlicková H., Machova I., et al. Subpopulations of Staphylococcus aureus clonal complex 121 are associated with distinct clinical entities. PLoS One 2013, 8:e58155. 10.1371/journal.pone.0058155.
120. Yang L., Jelsbak L., Marvig R.L., Damkiær S., Workman C.T., Rau M.H., et al. Evolutionary dynamics of bacteria in a human host environment. PNAS 2011, 108:7481-7486. 10.1073/pnas.1018249108.
121. Comas I., Borrell S., Roetzer A., Rose G., Malla B., Kato-Maeda M., et al. Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes. Nat. Genet. 2011, 44:106-110. 10.1038/ng.1038.
122. Lieberman T.D., Michel J.-B., Aingaran M., Potter-Bynoe G., Roux D., Davis M.R., et al. Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat. Genet. 2011, 43:1275-1280. 10.1038/ng.997.
123. Wingard J.R., Merz W.G., Rinaldi M.G., Miller C.B., Karp J.E., Saral R. Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients. Antimicrob. Agents Chemother. 1993, 37:1847-1849. 10.1128/AAC.37.9.1847.
124. Price M.F., LaRocco M.T., Gentry L.O. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother. 1994, 38:1422-1424. 10.1128/AAC.38.6.1422.
125. Pfaller M.A., Barry A.L. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method. Mycopathologia 1995, 130:3-9. 10.1007/BF01104343.
126. Pfaller M.A., Messer S.A., Boyken L., Tendolkar S., Hollis R.J., Diekema D.J. Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002 2004, 42:3142-3146.
127. Pfaller M.A., Castanheira M., Lockhart S.R., Ahlquist A.M., Messer S.A., Jones R.N. Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata 2012, 50:1199-1203. 10.1128/JCM.06112-11.
128. Pfaller M.A., Castanheira M., Messer S.A., Moet G.J., Jones R.N. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY antimicrobial surveillance program (2008-2009). Diagn. Microbiol. Infect. Dis. 2010, 68:278-283.
129. Pfaller M.A., Espinel-IngroffA., Canton E., Castanheira M., Cuenca-Estrella M., Diekema D.J., et al. Wild-type MIC distributions and epidemiological cutoffvalues for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J. Clin. Microbiol. 2012, 50:2040-2046. 10.1128/JCM.00248-12.
130. Zimbeck A.J., Iqbal N., Ahlquist A.M., Farley M.M., Harrison L.H., Chiller T., et al. FKS mutations and elevated echinocandin MIC values among Candida glabrata isolates from U.S. population-based surveillance. Antimicrob. Agents Chemother. 2010, 54:5042-5047. 10.1128/AAC.00836-10.
131. Lockhart S.R., Iqbal N., Cleveland A.A., Farley M.M., Harrison L.H., Bolden C.B., et al. Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011. J. Clin. Microbiol. 2012, 50:3435-3442. 10.1128/JCM.01283-12.
132. Cleary J.D., Garcia-Effron G., Chapman S.W., Perlin D.S. Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment. Antimicrob. Agents Chemother. 2008, 52:2263-2265. 10.1128/AAC.01568-07.
133. Thompson G.R., Wiederhold N.P., Vallor A.C., Villareal N.C., Lewis J.S., Patterson T.F. Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob. Agents Chemother. 2008, 52:3783-3785. 10.1128/AAC.00473-08.
134. Chapeland-Leclerc F., Hennequin C., Papon N., Noël T., Girard A., Socié G., et al. Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient. Antimicrob. Agents Chemother. 2010, 54:1360-1362. 10.1128/AAC.01138-09.
135. Costa-de-Oliveira S., Marcos Miranda I., Silva R.M., Pinto A., Silva E., Rocha R., Amorim A., et al. FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy. Antimicrob. Agents Chemother. 2011, 55:1312-1314.
136. Garcia-Effron G., Chua D.J., Tomada J.R., DiPersio J., Perlin D.S., Ghannoum M., et al. Novel FKS mutations associated with echinocandin resistance in Candida species. Antimicrob. Agents Chemother. 2010, 54:2225-2227. 10.1128/AAC.00998-09.
137. Kofteridis D.P., Lewis R.E., Kontoyiannis D.P. Caspofungin-non-susceptible Candida isolates in cancer patients. J. Antimicrob. Chemother. 2010, 65:293-295. 10.1093/jac/dkp444.
138. Pfeiffer C.D., Garcia-Effron G., Zaas A.K., Perfect J.R., Perlin D.S., Alexander B.D. Breakthrough invasive candidiasis in patients on micafungin 2010, 48:2373-2380. 10.1128/JCM.02390-09.
139. Sun H.-Y., Singh N. Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review. Int. J. Antimicrob. Agents 2010, 35:211-218. 10.1016/j.ijantimicag.2009.09.020.
140. Sprouffske K., Merlo L.M.F., Gerrish P.J., Maley C.C., Sniegowski P.D. Cancer in light of experimental evolution review. Curr. Biol. 2012, 22:R762-R771. 10.1016/j.cub.2012.06.065.
141. Yates L.R., Campbell P.J. Evolution of the cancer genome. Nat. Rev. Genet. 2012, 13:795-806. 10.1038/nrg3317.
142. Gillies R.J., Verduzco D., Gatenby R.A. Evolutionary dynamics of carcinogenesis and why targeted therapy does not work. Nat. Rev. Cancer 2012, 12:487-493. 10.1038/nrc3298.
143. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724. 10.1038/nature07943.
144. Navin N., Hicks J. Future medical applications of single-cell sequencing in cancer. Genome Med 2011, 3(5):31.
145. Navin N., Kendall J., Troge J., Andrews P., Rodgers L., McIndoo J., et al. Tumour evolution inferred by single-cell sequencing. Nature 2011, 472:90-94. 10.1038/nature09807.
146. Nawy T. Single-cell sequencing. Nat. Methods 2014, 11:18.
147. Drake J.W. A constant rate of spontaneous mutation in DNA-based microbes. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:7160-7164.
148. George D.J., Dionne C.A., Jani J., Angeles T., Murakata C., Lamb J., et al. Sustained in vivo regression of dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555). Cancer Res. 1999, 59:2395-2401.
149. Boon M.E., Trott P.A., van Kaam H., Kurver P.J., Leach A., Baak J.P. Morphometry and cytodiagnosis of breast lesions. Virchows Arch. A Pathol. Anat. Histol. 1982, 396:9-18.
150. Michaelson J.S., Cheongsiatmoy J.A., Dewey F., Silverstein M.J., Sgroi D., Smith B., et al. Spread of human cancer cells occurs with probabilities indicative of a nongenetic mechanism. Br. J. Cancer 2005, 93:1244-1249. 10.1038/sj.bjc.6602848.
151. McFarland C.D., Korolev K.S., Kryukov G.V., Sunyaev S.R., Mirny L.A. Impact of deleterious passenger mutations on cancer progression. PNAS 2013, 110:2910-2915. 10.1073/pnas.1213968110.
152. Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 2003, 4:346-358. 10.1038/nrg1066.
153. Bushman F., Lewinski M., CiuffiA., Barr S., Leipzig J., Hannenhalli S., et al. Genome-wide analysis of retroviral DNA integration. Nat. Rev. Microbiol. 2005, 3:848-858. 10.1038/nrmicro1263.
154. NeffN.F., Quake S.R., Lu R., Weissman I.L. Tracking single hematopoietic stem cells in vivo using high-throughput sequencing in conjunction with viral genetic barcoding. Nat. Biotechnol. 2011, 29:928-933. 10.1038/nbt.1977.
155. Joung J.K., Sander J.D. TALENs: a widely applicable technology for targeted genome editing. Nat. Rev. Mol. Cell Biol. 2012, 14:49-55. 10.1038/nrm3486.
156. Mali P., Yang L., Esvelt K.M., Aach J., Guell M., DiCarlo J.E., et al. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826. 10.1126/science.1232033.
157. Ran F.A., Hsu P.D., Lin C.-Y., Gootenberg J.S., Konermann S., Trevino A.E., et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 2013, 154:1380-1389. 10.1016/j.cell.2013.08.021.
158. Hwang W.Y., Fu Y., Reyon D., Maeder M.L., Tsai S.Q., Sander J.D., et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 2013, 31:227-229. 10.1038/nbt.2501.
159. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823. 10.2307/23365968?ref=search-gateway:38d92c8e93a5ab404633889567e42f2e.
160. Littlewood T.D., Hancock D.C., Danielian P.S., Parker M.G., Evan G.I. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins 1995, 23:1686-1690.
161. Vasioukhin V., Degenstein L., Wise B., Fuchs E. The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:8551-8556.
162. Lois C., Hong E.J., Pease S., Brown E.J., Baltimore D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 2002, 295:868-872. 10.1126/science.1067081.
163. Malausa T., Gilles A., Meglécz E., Blanquart H., Duthoy S., Costedoat C., et al. High-throughput microsatellite isolation through 454 GS-FLX titanium pyrosequencing of enriched DNA libraries. Mol. Ecol. Resour. 2011, 11:638-644. 10.1111/j.1755-0998.2011.02992.x.
164. Genome-wide in situ exon capture for selective resequencing. Nat. Genet. 2007, 39:1522-1527. 10.1038/ng.2007.42.
165. Gnirke A., Melnikov A., Maguire J., Rogov P., LeProust E.M., Brockman W., et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat. Biotechnol. 2009, 27:182-189. 10.1038/nbt.1523.